Form 4: Quest Diagnostics CEO James E. Davis Reports Stock Transactions
SEC Form 4 Filing
Quest Diagnostics CEO James E. Davis reports acquisition and disposition of company stock related to vesting of restricted stock units and settlement of performance stock awards.
Summary
- On March 3, 2025, James E. Davis, CEO and President of Quest Diagnostics, disposed of 1,662 shares of common stock at $173.74 to cover tax withholding obligations from vesting restricted stock units.
- On March 4, 2025, Davis acquired 61,917 shares of common stock at $173.74 related to the settlement of performance stock awards.
- Also on March 4, 2025, Davis disposed of 31,656 shares of common stock at $173.74 to cover tax withholding obligations from the settlement of the performance stock awards.
- Following these transactions, Davis beneficially owns 166,814 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive; it doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Disposition of 1,662 shares of common stock to cover tax withholding obligations. |
| 03/04/2025 | Acquisition of 61,917 shares of common stock in settlement of performance stock awards. |
| 03/04/2025 | Disposition of 31,656 shares of common stock to cover tax withholding obligations from the settlement of performance stock awards. |
| 03/05/2025 | Date of signature by Sean D. Mersten, Attorney in Fact for James E. Davis. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.